Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

P Cannon

Showing results (311-320 of 1,137) with videos related to

Pageof 114
Sort By:
Journal of Toxicology and Environmental Health|March 1, 1994
Antagonism of cyanide intoxication with murine carrier erythrocytes containing bovine rhodanese and sodium thiosulfateE P Cannon, P Leung, A Hawkins, et al.
Journal of the American College of Cardiology|January 20, 2010
Reduction in recurrent cardiovascular events with intensive lipid-lowering statin therapy compared with moderate lipid-lowering statin therapy after acute coronary syndromes from the PROVE IT-TIMI 22 (Pravastatin or Atorvastatin Evaluation and Infection Therapy-Thrombolysis In Myocardial Infarction 22) trialSabina A Murphy, Christopher P Cannon, Stephen D Wiviott, et al.
Journal of the American College of Cardiology|April 11, 2009
Interaction between cigarette smoking and clinical benefit of clopidogrelNihar R Desai, Jessica L Mega, Songtao Jiang, et al.
The American Journal of Cardiology|August 10, 2010
On-statin cholesteryl ester transfer protein mass and risk of recurrent coronary events (from the pravastatin or atorvastatin evaluation and infection therapy-thrombolysis in myocardial infarction 22 [PROVE IT-TIMI 22] study)Amit V Khera, Megan L Wolfe, Christopher P Cannon, et al.
Journal of Thrombosis and Thrombolysis|February 15, 2011
Impact of reduced glomerular filtration rate on outcomes in patients with ST-segment elevation myocardial infarction undergoing fibrinolysis: a CLARITY-TIMI 28 analysisShaheeda Ahmed, C Michael Gibson, Christopher P Cannon, et al.
Circulation. Cardiovascular Quality and Outcomes|April 14, 2011
Benefit of intensive statin therapy in women: results from PROVE IT-TIMI 22Quynh A Truong, Sabina A Murphy, Carolyn H McCabe, et al.
The American Journal of Cardiology|December 14, 2004
Safety of stress testing during the evolution of unstable angina pectoris or non-ST-elevation myocardial infarctionJuhana Karha, C Michael Gibson, Sabina A Murphy, et al.
Current Biology : CB|June 19, 2004
Individual protochordates have unique immune-type receptor repertoiresJohn P Cannon, Robert N Haire, Natasha Schnitker, et al.
Annals of Emergency Medicine|November 1, 1995
Victim as offender in youth violenceF P Rivara, J P Shepherd, D P Farrington, et al.
The American Journal of Cardiology|August 30, 2008
Is coding for myocardial infarction more accurate now that coding descriptions have been clarified to distinguish ST-elevation myocardial infarction from non-ST elevation myocardial infarction?Benjamin A Steinberg, William J French, Eric Peterson, et al.
Pageof 114

Showing results (311-320 of 1,137) with videos related to

Sort By:
Pageof 114
Journal of Toxicology and Environmental Health|March 1, 1994
Antagonism of cyanide intoxication with murine carrier erythrocytes containing bovine rhodanese and sodium thiosulfateE P Cannon, P Leung, A Hawkins, et al.
Journal of the American College of Cardiology|January 20, 2010
Reduction in recurrent cardiovascular events with intensive lipid-lowering statin therapy compared with moderate lipid-lowering statin therapy after acute coronary syndromes from the PROVE IT-TIMI 22 (Pravastatin or Atorvastatin Evaluation and Infection Therapy-Thrombolysis In Myocardial Infarction 22) trialSabina A Murphy, Christopher P Cannon, Stephen D Wiviott, et al.
Journal of the American College of Cardiology|April 11, 2009
Interaction between cigarette smoking and clinical benefit of clopidogrelNihar R Desai, Jessica L Mega, Songtao Jiang, et al.
The American Journal of Cardiology|August 10, 2010
On-statin cholesteryl ester transfer protein mass and risk of recurrent coronary events (from the pravastatin or atorvastatin evaluation and infection therapy-thrombolysis in myocardial infarction 22 [PROVE IT-TIMI 22] study)Amit V Khera, Megan L Wolfe, Christopher P Cannon, et al.
Journal of Thrombosis and Thrombolysis|February 15, 2011
Impact of reduced glomerular filtration rate on outcomes in patients with ST-segment elevation myocardial infarction undergoing fibrinolysis: a CLARITY-TIMI 28 analysisShaheeda Ahmed, C Michael Gibson, Christopher P Cannon, et al.
Circulation. Cardiovascular Quality and Outcomes|April 14, 2011
Benefit of intensive statin therapy in women: results from PROVE IT-TIMI 22Quynh A Truong, Sabina A Murphy, Carolyn H McCabe, et al.
The American Journal of Cardiology|December 14, 2004
Safety of stress testing during the evolution of unstable angina pectoris or non-ST-elevation myocardial infarctionJuhana Karha, C Michael Gibson, Sabina A Murphy, et al.
Current Biology : CB|June 19, 2004
Individual protochordates have unique immune-type receptor repertoiresJohn P Cannon, Robert N Haire, Natasha Schnitker, et al.
Annals of Emergency Medicine|November 1, 1995
Victim as offender in youth violenceF P Rivara, J P Shepherd, D P Farrington, et al.
The American Journal of Cardiology|August 30, 2008
Is coding for myocardial infarction more accurate now that coding descriptions have been clarified to distinguish ST-elevation myocardial infarction from non-ST elevation myocardial infarction?Benjamin A Steinberg, William J French, Eric Peterson, et al.
Pageof 114